The US interventional ophthalmic device market is estimated to reach nearly $2bn by 2017, according to a new report by Research and Markets.

Intraocular lenses, which consist of multifocal and accommodative lenses, represent the largest segment of the market.

Intraocular lenses market is expected to be driven by increase in demand for premium lenses.

Within the interventional ophthalmic device market, companies such as Abbott Medical Optics, Alcon, Bausch & Lomb, Lumenis, Iridex and Carl Zeiss Meditec lead the market, the report noted.